Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gerdes

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Neuroinformatics|April 7, 2012
Volume estimation of the thalamus using freesurfer and stereology: consistency between methodsSimon S Keller, Jan S Gerdes, Siawoosh Mohammadi, et al.
Veterinary Pathology|June 2, 2023
Histopathologic and molecular characterization of <i>Erethizon dorsatum</i> papillomavirus 1 and <i>Erethizon dorsatum</i> papillomavirus 2 infection in North American porcupines (<i>Erethizon dorsatum</i>)Zoe E Mack, Leonardo C Caserta, Randall W Renshaw, et al.
The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.
Cancer Genetics|April 21, 2011
Comparison of chromosomal aberrations in primary colorectal carcinomas to their pulmonary metastasesBernhard C Danner, Jan S Gerdes, Klaus Jung, et al.
The British Journal of Dermatology|April 12, 2019
Continued treatment with secukinumab is associated with high retention or regain of responseM Augustin, D Thaci, K Eyerich, et al.
The British Journal of Dermatology|October 28, 2016
The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasisC E M Griffiths, D Thaçi, S Gerdes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2023
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST studyS Gerdes, M Hoffmann, K Asadullah, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 11, 2024
Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS studyS Gerdes, R Ostendorf, A Süß, et al.
Leukemia|May 31, 2012
T-cell receptor diversity prevents T-cell lymphoma developmentS Newrzela, N Al-Ghaili, T Heinrich, et al.
Emerging Microbes & Infections|August 17, 2023
Infection and tissue distribution of highly pathogenic avian influenza A type H5N1 (clade 2.3.4.4b) in red fox kits (<i>Vulpes vulpes</i>)Brittany D Cronk, Leonardo Cardia Caserta, Melissa Laverack, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Neuroinformatics|April 7, 2012
Volume estimation of the thalamus using freesurfer and stereology: consistency between methodsSimon S Keller, Jan S Gerdes, Siawoosh Mohammadi, et al.
Veterinary Pathology|June 2, 2023
Histopathologic and molecular characterization of <i>Erethizon dorsatum</i> papillomavirus 1 and <i>Erethizon dorsatum</i> papillomavirus 2 infection in North American porcupines (<i>Erethizon dorsatum</i>)Zoe E Mack, Leonardo C Caserta, Randall W Renshaw, et al.
The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.
Cancer Genetics|April 21, 2011
Comparison of chromosomal aberrations in primary colorectal carcinomas to their pulmonary metastasesBernhard C Danner, Jan S Gerdes, Klaus Jung, et al.
The British Journal of Dermatology|April 12, 2019
Continued treatment with secukinumab is associated with high retention or regain of responseM Augustin, D Thaci, K Eyerich, et al.
The British Journal of Dermatology|October 28, 2016
The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasisC E M Griffiths, D Thaçi, S Gerdes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2023
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST studyS Gerdes, M Hoffmann, K Asadullah, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 11, 2024
Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS studyS Gerdes, R Ostendorf, A Süß, et al.
Leukemia|May 31, 2012
T-cell receptor diversity prevents T-cell lymphoma developmentS Newrzela, N Al-Ghaili, T Heinrich, et al.
Emerging Microbes & Infections|August 17, 2023
Infection and tissue distribution of highly pathogenic avian influenza A type H5N1 (clade 2.3.4.4b) in red fox kits (<i>Vulpes vulpes</i>)Brittany D Cronk, Leonardo Cardia Caserta, Melissa Laverack, et al.
Pageof 12